https://kite-pharma.org/newsroom/fda-approves-yescarta-label-update 2026-02-06 monthly 0.7 Kite Pharma Newsroom en 2026-02-06 FDA Approves Label Update for Yescarta® FDA approval, Yescarta, PCNSL, CAR-T therapy https://kite-pharma.org/newsroom/kite-presents-data-at-ash 2025-12-15 monthly 0.7 Kite Pharma Newsroom en 2025-12-15 Kite Presents New Data at ASH ASH conference, clinical data, CAR-T therapy https://kite-pharma.org/newsroom/next-generation-car-t-therapies 2025-11-20 monthly 0.7 Kite Pharma Newsroom en 2025-11-20 Next-Generation CAR T Therapies Show Promise next-generation CAR-T, KITE-753, KITE-363 https://kite-pharma.org/newsroom/gilead-acquires-arcellx 2025-10-10 monthly 0.7 Kite Pharma Newsroom en 2025-10-10 Gilead to Acquire Arcellx Gilead, Arcellx, acquisition, multiple myeloma https://kite-pharma.org/newsroom/manufacturing-expansion 2025-09-15 monthly 0.7 Kite Pharma Newsroom en 2025-09-15 Manufacturing Expansion Announced manufacturing, expansion, capacity https://kite-pharma.org/newsroom/imagine-1-trial-results 2025-08-22 monthly 0.7 Kite Pharma Newsroom en 2025-08-22 iMMagine-1 Study Results iMMagine-1, anito-cel, multiple myeloma, clinical trial